Evidence map›Paper›PMID 38133334›Full record

ArticlePathogens (Basel, Switzerland)2023

Rania Hamada, Samy Metwally, Ryosuke Matsuura, Liushiqi Borjigin, Chieh-Wen Lo, Alsagher O Ali, Adel E A Mohamed, Satoshi Wada, Yoko Aida

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. First Identification ofPathogens (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Rania HamadaViral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.ORCID 0009-0008-7104-6643
Samy MetwallyViral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Ryosuke MatsuuraViral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.ORCID 0009-0000-9487-9615
Liushiqi BorjiginViral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.ORCID 0009-0001-8757-0561
Chieh-Wen LoViral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.ORCID 0000-0003-1890-4916
Alsagher O AliDepartment of Animal Medicine, Faculty of Veterinary Medicine, South Valley University, Qena City 83523, Egypt.
Adel E A MohamedDepartment of Animal Medicine, Faculty of Veterinary Medicine, South Valley University, Qena City 83523, Egypt.
Satoshi WadaPhotonics Control Technology Team, RIKEN Center for Advanced Photonics, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Yoko AidaViral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.ORCID 0000-0001-7400-3587
RIKEN · JPDamanhour University · EGSouth Valley University · EGRIKEN Center for Advanced Photonics · JP

Funding

Embassy of Egypt Culture Education and Science BureauJapan Racing Association Livestock Promotional SubsidyJapan Society for the Promotion of Science 16H02590
6 · The paper itself

Abstract

Bovine leukemia virus (BLV) is the etiological agent of enzootic bovine leukosis, the most prevalent neoplastic disease of cattle worldwide. The immune response to BLV and disease susceptibility and resistance in cattle are strongly correlated with the bovine leukocyte antigen (

Indexed as

association studyBLVBLV infectionBoLA-DRB3Holstein cattlepolymorphismproviral load

Identifiers

PMID38133334
PMCPMC10746042
OpenAlexW4389787680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.